Cytokine (proinflammatory/anti-inflammatory) analysis in Myalgic Encephalomyelitis Chronic Fatigue Syndrome (MECFS) patients: A Two Phase Design. Assessing differences in cytokine levels across two time points.

South Australian Health & Medical Research Institute0 个研究点目标入组 60 人开始时间: 2020年11月3日最近更新: 2020年11月9日

试验速览

暂无简介。

•Participants will have a diagnosis of ME/CFS. They will be based in South Australia unless special arrangements can be organised to collect bloods interstate. A formal diagnosis of ME/CFS will have been made by a general practitioner or medical specialist. They will also consent for their GP to be provided with information if required for example feedback about clinical levels of moderate to severe depression. Healthy participants will be those who do not have other current physical health or mental health problems. They will also consent for their GP to be provided with information if required for example feedback about clinical levels of moderate to severe depression.

•Exclusion criterion includes hormonal disorders, major physical or mental health disorders, or outside of the age range. Exclusion criteria include pregnancy, other diseases requiring medication that may affect the results, alcohol or substance abuse or dependence. Other physical disorders that may confound the measurements listed earlier, such as anaemia, or a thyroid disorder. Any mental health disorder that requires medication, psychosis, affective disorders. Low dosages of antidepressant for the purpose of sleep will be accepted. Being unable to understand the consent process due to language or an inability to read English. Must be at least 18 years of age, and up to 65 years.
•Morbid Obesity will be an exclusion factor i.e. must have a BMI <40 (35 equates to the WHO obesity type ii and 40 morbidly obese).

发起方

South Australian Health & Medical Research Institute